Influx Healthtech Financials

NSE: INFLUX

₹288.60

₹-2.75 (-0.94%)

As on 07-Sep-2026IST

Market cap

₹668 Cr

Revenue (TTM)

₹105 Cr

P/E Ratio

32.5

P/B Ratio

--

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	104.85	99.97	76.06	59.20	--	--
Total Income	104.99	100.02	76.07	59.20	--	--
Total Expenditure	84.28	83.00	65.33	53.03	--	--
EBITDA	20.58	16.96	10.72	6.17	--	--
Depreciation	2.82	1.85	0.94	0.12	--	--
EBIT	17.75	15.11	9.79	6.05	--	--
Interest	0.01	0.22	0.06	0.04	--	--
Other Income	0.13	0.05	0.01	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	17.88	14.93	9.74	6.01	--	--
Provision for Tax	4.51	3.80	2.54	1.57	--	--
Profit after Tax	13.37	11.13	7.19	4.44	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	36.15	22.78	11.65	4.46	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.05	0.05	0.26	0.17	--	--
Current Liabilities	33.92	17.98	16.39	12.96	--	--
Total Liabilities	70.30	41.10	28.30	17.59	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	21.10	15.14	7.48	3.29	--	--
Current Assets	49.02	25.68	20.82	14.30	--	--
Total Assets	70.30	41.10	28.30	17.59	--	--
Total Debt*	0.22	0.32	0.80	0.61	--	--
Net Current Assets	15.10	7.70	4.43	1.34	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	7.06	8.94	6.43	2.91	--	--
Cash Flow from Investing Activities	-8.64	-8.36	-4.52	-2.86	--	--
Cash from Financing Activities	-0.11	-0.53	0.18	1.39	--	--
Net Cash Inflow / Outflow	-1.70	0.06	2.08	1.44	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	7.36	6.13	3.96	2.44	--	--
Cash EPS (₹)	8.92	7.15	4.48	2.51	--	--
Adjusted Book Value (₹)	19.91	12.55	6.42	2.46	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	3.89	3,577.00	2,571.00	1,164.88	--	--
Free Cash Flow per Share (₹)	-0.67	-277.52	762.96	-127.36	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	60.15	85.26	111.85	119.35	--	--
ROE (%)	45.37	64.64	89.32	99.54	--	--
ROA (%)	24.10	32.20	31.35	25.23	--	--
EBIT Margin (%)	16.93	15.11	12.87	10.22	--	--
Net Margin (%)	12.73	11.13	9.46	7.49	--	--
Cash Profit Margin (%)	15.44	12.99	10.69	7.70	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	4.89	31.44	28.47	--	--	--
EBIT Growth (%)	17.51	54.37	61.80	--	--	--
Net Profit Growth (%)	20.11	54.68	62.15	--	--	--
EPS Growth (%)	20.11	54.68	62.15	--	--	--
Book Value Growth (%)	58.68	95.51	161.40	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.79	-0.19	-0.25	-0.13	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.01	0.01	0.07	0.14	--	--
Short term debt to equity ratio	0.01	0.01	0.06	0.11	--	--
Current Ratio	1.45	1.43	1.27	1.10	--	--
Quick Ratio	1.06	1.12	1.15	0.97	--	--
Interest Coverage	3,576.82	67.66	163.54	144.68	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	30.94	15.92	18.18	17.42	--	--
Asset Turnover	1.89	2.89	3.31	3.37	--	--
Receivable days	84.17	54.30	57.91	63.57	--	--
Inventory Days	32.50	13.54	8.92	10.82	--	--
Payable days	183.25	103.84	112.02	113.84	--	--
Cash Conversion Cycle	-66.58	-36.00	-45.19	-39.45	--	--